Pharmaceuticals for Elders: Why Innovation Matters
Image
Author: Wertheimer, A.
The current policy debate over drug-benefit reform and improved access to needed medicines for elders has generated considerable confusion and many misperceptions regarding the nature and value of incremental pharmaceutical innovation. Cumulatively, these new medicines allow for precision treatment of the individual needs of diverse patients, which is especially important for optimal treatment of older patients, because age-related physiological changes and individual differences may produce markedly diverse responses to medications in older adults.